Isotretinoin, Interferon Alfa-2b, and Paclitaxel in Treating Patients With Stage IV, Recurrent, or Persistent Cervical Cancer

This study is currently recruiting participants.

Study NCT00138151 Information provided by National Cancer Institute (NCI)

First Received: August 29, 2005 Last Updated: June 27, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	December 2008 (Final data collection date for primary outcome measure)